Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
136 USD | -1,28% | +3,02% | +3,21% |
Omzet 2024 * | 2,21 mld. 2,07 mld. | Omzet 2025 * | 2,52 mld. 2,36 mld. | Marktkapitalisatie | 13,68 mld. 12,79 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 490 mln. 458 mln. | Nettowinst (verlies) 2025 * | 666 mln. 623 mln. | EV/omzet 2024 * | 5,24 x |
Nettoliquiditeiten 2024 * | 2,09 mld. 1,95 mld. | Nettoliquiditeiten 2025 * | 2,88 mld. 2,69 mld. | EV/omzet 2025 * | 4,29 x |
K/w-verhouding 2024 * |
28,8
x | K/w-verhouding 2025 * |
21,3
x | Werknemers | 1.400 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,73% |
Recentste transcriptie over Neurocrine Biosciences, Inc.
1 dag | -1,28% | ||
1 week | +3,02% | ||
Lopende maand | -1,40% | ||
1 maand | -3,66% | ||
3 maanden | -4,33% | ||
6 maanden | +26,01% | ||
Lopend jaar | +3,21% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Director of Finance/CFO | 44 | 01-11-17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01-04-99 |
George Morrow
BRD | Director/Board Member | 72 | 01-10-15 |
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
13.65% | 215 M€ | +10,68% | - | |
3.81% | 1 M€ | -5,79% | - | |
1.85% | 8 M€ | +2,44% | ||
1.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 136 | -1,28% | 717 575 |
25-04-24 | 137,8 | -0,87% | 735 781 |
24-04-24 | 139 | -0,80% | 927 988 |
23-04-24 | 140,1 | +4,81% | 1 607 818 |
22-04-24 | 133,7 | +1,26% | 575 067 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,21% | 13,68 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+33,54% | 12,17 mld. | |
-24,71% | 8,24 mld. |